Blue Owl Capital Inc (OWL)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Blue Owl Capital Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 10.30 $ — 17% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
7 of 10 Solid growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 28.0% passed
- More than 10% revenue growth is expected for the coming year 11.2% passed
- Share count grows by less than 3% a year 15.3% failed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 66.8% passed
- Gross margin at 40% or higher and without meaningful erosion 55.4% passed
- Goodwill from acquisitions does not grow faster than revenue 45.1% passed
- Net debt below twice EBITDA 3.9 x EBITDA failed
- Operating cash flow covers the profits of the last three years 2,962 m passed
- Return on capital at 15% or higher, or up versus two years ago 5.5% passed
- Insiders hold at least 10% or are net buyers 0.1% failed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 20.2% above the current price.
- Consensus
- Sell
- Analyst Ratings
- 15
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 0.89 | 0.87 – 0.90 | 2,845 | 5.4% | 16 |
| 12/31/2027 | 0.99 | 0.93 – 1.06 | 3,136 | 11.5% | 16 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 0.04 | 0.40 | 631 | 27.80 | 3.30 | 324 | 310 |
| 2025: Q1 | 0.01 | -76.90 | 684 | 33.10 | 1.10 | 18 | 4 |
| 2025: Q2 | 0.03 | -57.80 | 703 | 27.90 | 2.50 | 423 | 413 |
| 2025: Q3 | 0.01 | -82.80 | 728 | 21.20 | 0.90 | 433 | 423 |
| 2025: Q4 | 0.07 | 93.00 | 756 | 19.70 | 6.30 | 383 | 359 |
| 2026: Q1 | 0.02 | 96.10 | 754 | 10.30 | 2.10 | 103 | 89 |
| 2026: Q2 | 0.02 | -33.30 | 137 | -80.50 | 8.30 | 461 | 453 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2017 | – | 0 | 0 | 0.00 | 0 | 5 | 46 |
| 2018 | 121 | -2 | 2 | 0.01 | 19 | – | – |
| 2019 | 191 | 27 | 23 | 0.07 | 44 | -353 | 57 |
| 2020 | 250 | -59 | -78 | -2.26 | 5 | -508 | 122 |
| 2021 | 824 | -927 | -376 | -1.14 | 282 | 5,848 | 8,266 |
| 2022 | 1,370 | -2 | -9 | -0.02 | 728 | 1,605 | 8,893 |
| 2023 | 1,732 | 318 | 54 | 0.11 | 949 | 1,528 | 8,818 |
| 2024 | 2,295 | 607 | 110 | 0.20 | 1,000 | 2,128 | 10,992 |
| 2025 | 2,870 | 627 | 79 | 0.12 | 1,256 | 2,205 | 12,468 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Blue Owl Capital Inc. ist als alternativer Vermögensverwalter in den USA tätig.
| CEO Insider Trades (12 Mo.) | buying own stock |
|---|---|
| Employees | 1,380 |
| Headquarters | New York, NY |
| Address | 399 Park Avenue, 10022 New York, United States |
| Phone | 212 419 3000 |
| Website | blueowl.com |
| IPO Date | 14. Dec 2020 |
| ISIN | US09581B1035 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Douglas Irving Ostrover | Co-Founder, Chairman & Co-CEO | 1962 |
| Marc S. Lipschultz | Co-Founder, Co-CEO & Director | 1969 |
| Michael Douglass Rees | Co-Founder, Co-President & Director | 1975 |
| Craig William Packer | Head of Credit, Co-Founder, Co-President, Senior MD & Director | 1966 |
| Marc Zahr | Co-President & Director | 1980 |
| Alan Jay Kirshenbaum CPA | Chief Financial Officer | 1971 |
| Jennifer Brouse | Senior MD & Director | 1989 |
| Andrew Robert Polland | Chief Operating Officer | 1976 |
| Ann Dai | MD & Head of Investor Relations | – |
| Neena Ann Reddy J.D. | Chief Legal Officer, General Counsel & Secretary | 1978 |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.